Insider Sell: EVP, President Diagnostics & COO Mark Schroeder Sells Shares of Laboratory ...
Mark Schroeder, Executive Vice President, President of Diagnostics, and Chief Operating Officer of Laboratory Corp of America Holdings (NYSE:LH), has sold 5,048 shares of the company on March 7, 2024, according to a recent SEC filing.Laboratory Corp of America Holdings, commonly known as LabCorp, is a leading global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. Through its unparalleled diagnostics and drug development capabilities, LabCorp provides insights and accelerates innovations to improve health and improve lives.Over the past year, the insider has sold a total of 6,548 shares and has not made any purchases of the company's stock. This latest transaction continues a trend of insider sales at Laboratory Corp of America Holdings, with a total of 10 insider sells and no insider buys occurring over the past year.
On the day of the sale, shares of Laboratory Corp of America Holdings were trading at $218.45, giving the company a market capitalization of $18.278 billion. The price-earnings ratio of the company stands at 46.74, which is above both the industry median of 29.245 and the historical median price-earnings ratio for the company.According to the GuruFocus Value chart, with a share price of $218.45 and a GF Value of $224.99, Laboratory Corp of America Holdings has a price-to-GF-Value ratio of 0.97, indicating that the stock is Fairly Valued.
The GF Value is determined by considering historical trading multiples such as price-earnings ratio, price-sales ratio, price-book ratio, and price-to-free cash flow, along with a GuruFocus adjustment factor based on the company's past returns and growth, and future business performance estimates from Morningstar analysts.The recent insider sell by Mark Schroeder may provide investors with an insight into the insider's perspective on the stock's valuation and future prospects. However, investors are always encouraged to conduct their own research and consider a wide range of factors before making investment decisions.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
This article first appeared on GuruFocus.
